Demir, A. B. Et Al. 2023. Superoxide Dismutase 2 protein levels in blood may act as a prognostic marker for high-risk neuroblastoma patients.. JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , vol.7, no.1 , 196-213.

Demir, A. B., Altun, Z. S., Aktaş, S., & Olgun, H. N., (2023). Superoxide Dismutase 2 protein levels in blood may act as a prognostic marker for high-risk neuroblastoma patients.. JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , vol.7, no.1, 196-213.

Demir, Ayşe Et Al. "Superoxide Dismutase 2 protein levels in blood may act as a prognostic marker for high-risk neuroblastoma patients.," JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , vol.7, no.1, 196-213, 2023

Demir, Ayşe B. Et Al. "Superoxide Dismutase 2 protein levels in blood may act as a prognostic marker for high-risk neuroblastoma patients.." JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , vol.7, no.1, pp.196-213, 2023

Demir, A. B. Et Al. (2023) . "Superoxide Dismutase 2 protein levels in blood may act as a prognostic marker for high-risk neuroblastoma patients.." JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , vol.7, no.1, pp.196-213.

@article{article, author={Ayşe Banu Demir Et Al. }, title={Superoxide Dismutase 2 protein levels in blood may act as a prognostic marker for high-risk neuroblastoma patients.}, journal={JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES}, year=2023, pages={196-213} }